BackNorth China Pharmaceutical Company Overview

North China Pharmaceutical Company Goodwill

Track North China Pharmaceutical Company's goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

North China Pharmaceutical Company Goodwill History

Loading

North China Pharmaceutical Company vs. peers: Goodwill Comparison

Loading

North China Pharmaceutical Company Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

North China Pharmaceutical Company (600812.SS) FAQ

The latest goodwill for 600812.SS is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside North China Pharmaceutical Company's historical trend and sector peers before judging valuation or financial health.

Over the past year, 600812.SS's goodwill moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in North China Pharmaceutical Company's operating scale or balance-sheet position.

A goodwill figure of $0 for 600812.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 600812.SS's goodwill ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.